<i>CD147</i> rs8259T>A Variant Confers Susceptibility to COVID-19 Infection within the Mexican Population
Background: Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clinical manifestations of COVID-19 range from mild flu-like symptoms to severe respiratory failure. Nowadays, extracellular matrix metalloproteinase inducer (EMMPRIN), also...
Main Authors: | Luis M. Amezcua-Guerra, Carlos A. Guzmán-Martín, Isela Montúfar-Robles, Rashidi Springall, Adrián Hernández-Díazcouder, Rosa Elda Barbosa-Cobos, Fausto Sánchez-Muñoz, Julián Ramírez-Bello |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-07-01
|
Series: | Microorganisms |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-2607/11/8/1919 |
Similar Items
-
Soluble CD147 (BSG) as a Prognostic Marker in Multiple Myeloma
by: Piotr Łacina, et al.
Published: (2022-01-01) -
Matrix Metalloproteinases and Their Inhibitors in Pulmonary Fibrosis: EMMPRIN/CD147 Comes into Play
by: Lourdes Chuliá-Peris, et al.
Published: (2022-06-01) -
Development of a novel human CD147 knock-in NSG mouse model to test SARS-CoV-2 viral infection
by: Saiaditya Badeti, et al.
Published: (2022-06-01) -
CD147 Is Essential for the Development of Psoriasis via the Induction of Th17 Cell Differentiation
by: Aoi Okubo, et al.
Published: (2021-12-01) -
The CD147 Protein Complex Is Involved in Entry of Chikungunya Virus and Related Alphaviruses in Human Cells
by: Lien De Caluwé, et al.
Published: (2021-02-01)